Skip to Main Content

Paper Details

Developing an IV Ketamine Clinic for Treatment-Resistant Depression: a Primer.
Psychopharmacol Bull
2
2021
Author NameAffiliation
William CoryellUniversity of Michigan, Mayo Clinic, Pine Rest Christian Mental Health Services, University of Iowa, University of California San Francisco, Johns Hopkins University School of Medicine, Emory University School of Medicine, Maryland MyMD Pharmaceuticals Inc
Fernando S GoesUniversity of Michigan, Mayo Clinic, Pine Rest Christian Mental Health Services, University of Iowa, University of California San Francisco, Johns Hopkins University School of Medicine, Emory University School of Medicine, Maryland MyMD Pharmaceuticals Inc
Balwinder SinghUniversity of Michigan, Mayo Clinic, Pine Rest Christian Mental Health Services, University of Iowa, University of California San Francisco, Johns Hopkins University School of Medicine, Emory University School of Medicine, Maryland MyMD Pharmaceuticals Inc
Mark A FryeUniversity of Michigan, Mayo Clinic, Pine Rest Christian Mental Health Services, University of Iowa, University of California San Francisco, Johns Hopkins University School of Medicine, Emory University School of Medicine, Maryland MyMD Pharmaceuticals Inc
  • 1 - 4

Datasets